Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
BJ Sherman, MJ Sofis, JT Borodovsky… - … Behaviors: Journal of …, 2021 - europepmc.org
Objective Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Evaluating Cannabis Use Risk Reduction as an Alternative Clinical Outcome for Cannabis Use Disorder
BJ Sherman, MJ Sofis, JT Borodovsky, KM Gray… - 2021 - search.proquest.com
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
[PDF][PDF] Evaluating Cannabis Use Risk Reduction as an Alternative Clinical Outcome for Cannabis Use Disorder
BJ Sherman, MJ Sofis, JT Borodovsky, KM Gray… - 2021 - researchgate.net
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder
BJ Sherman, MJ Sofis, JT Borodovsky, KM Gray… - 2022 - pubmed.ncbi.nlm.nih.gov
Objective Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
BJ Sherman, MJ Sofis… - Psychology of …, 2022 - search.pdh.ebscohost.com
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
BJ Sherman, MJ Sofis, JT Borodovsky… - Psychology of …, 2022 - psycnet.apa.org
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
[HTML][HTML] Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
BJ Sherman, MJ Sofis, JT Borodovsky… - … of addictive behaviors …, 2022 - ncbi.nlm.nih.gov
Objective: Abstinence is rarely achieved in clinical trials for Cannabis Use Disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …